Abstract
Persistent pneumothorax is a life-threatening complication that can occur after congenital cardiac surgery. Traditional treatment such as chest tube drainage may not be effective in managing this condition. This study presents a new minimally invasive method for treating persistent pneumothorax using platelet-rich plasma–fibrin glue (PRP–FG). The method has been successful in treating postoperative chylothorax in previous studies, and its use has decreased morbidity, mortality, and hospital stay in chylothorax patients. Ten patients with persistent pneumothorax following cardiothoracic surgery (3 TAPVC, 2 d-TGA, 2 VSD + IAA,1 TRUNCUS + TAPVC, 1 VSD + COA, 1 GLENN), who did not respond to conservative management, underwent treatment with PRP–FG. Follow-up was done for a period of 1–4 years. The age and diagnoses of pneumothorax after surgery were 85.5 ± 36.0 days and 62.4 ± 34.3 h, respectively. Persistent pneumothorax of 8 patients (80%) was cured completely after PRP–FG injection. PRP–FG therapy was failed in two patients who died. All cured patients had a normal life without any complications during follow-up. After PRP–FG injection, 3 patients stopped bubbling at one-time injection, 3 patients stopped bubbling at two-time injection, and 2 patients stopped bubbling at three-time injection. Two patients died during treatment; in these cases, one-time injections were done which was not successful. Persistent pneumothorax after congenital–cardiac surgery can be treated successfully with PRP–FG. This bedside minimal-invasive procedure may significantly decrease the morbidity and mortality rate. Further research is needed to confirm the efficacy of this promising treatment through multicentre clinical trials.
Similar content being viewed by others
Data availability
Data are available from the corresponding author on a reasonable request.
References
Walker SP, Hallifax R, Rahman NM, Maskell NA (2022) Challenging the paradigm of persistent air leak: are we prolonging the problem? Am J Respir Crit Care Med 206(2):145–149
Luh S-p (2010) Diagnosis and treatment of primary spontaneous pneumothorax. J Zhejiang Univ Sci B 11:735–744
Ghisalberti M, Guerrera F, De Vico A, Bertolaccini L, De Palma A, Fiorelli A, Paladini P, Ruffini E, Crisci R, Nosotti M, Mendogni P (2020) Age and clinical presentation for primary spontaneous pneumothorax. Heart Lung Circ 29:1648–1655
Choi W-I (2014) Pneumothorax. Tuberc Respir Dis 76(3):99–104
Chaturvedi A, Lee S, Klionsky N, Chaturvedi A (2016) Demystifying the persistent pneumothorax: role of imaging. Insights Imaging 7(3):411–429
Sabanathan S, Richardson J (1994) Management of postpneumonectomy bronchopleural fistulae. A review. J Cardiovasc Surg 35(5):449–457
Huseynov M (2020) A first case report of neonatal persistent pneumothorax treated with an autologous blood patch. Turkish Arch Pediatrics/Türk Pediatri Arşivi 55(4):438
Alamdari DH, Asadi M, Rahim AN, Maddah G, Azizi S, Shahidsales S et al (2018) Efficacy and safety of pleurodesis using platelet-rich plasma and fibrin glue in management of postoperative chylothorax after esophagectomy. World J Surg 42:1046–1055
Tashnizi MA, Maleki MH, Javedanfar O, Damsaz M, Alamdari AH, Seifalian AM et al (2020) Platelet-rich plasma fibrin glue for treatment of chylothorax following cavopulmonary connections. Eur J Cardiothorac Surg 58(6):1269–1273
Dietrich W, Ebell A, Busley R, Boulesteix A-L (2007) Aprotinin and anaphylaxis: analysis of 12,403 exposures to aprotinin in cardiac surgery. Ann Thorac Surg 84(4):1144–1150
Li Z, Huang H, Li Q, Zarogoulidis K, Kougioumtzi I, Dryllis G et al (2014) Pneumothorax: observation. J Thorac Dis 6(Suppl 4):S421
Pierson DJ, Hordon CA, Bates PW (1986) Persistent bronchopleural air leak during mechanical ventilation: a review of 39 cases. Chest 90(3):321–323
Lazarus DR, Casal RF (2017) Persistent air leaks: a review with an emphasis on bronchoscopic management. J Thorac Dis 9(11):4660
Arayici S, Simsek GK, Oncel MY, Yilmaz Y, Canpolat FE, Dilmen U (2013) Povidone-iodine for persistent air leak in an extremely low birth weight infant. J Pediatr Surg 48(5):e21–e23
Berger JT, Gilhooly J (1993) Fibrin glue treatment of persistent pneumothorax in a premature infant. J Pediatr 122(6):958–960
Sarkar S, Hussain N, Herson V (2003) Fibrin glue for persistent pneumothorax in neonates. J Perinatol 23(1):82–84
Drovandi L, Cianchi I, Pratesi S, Dani C (2018) Fibrin glue pleurodesis for pneumothorax in extremely preterm infants: a case report and literature review. Ital J Pediatr 44:1–5
Canpolat FE, Yurdakok M, Yurttutan S (2006) Fibrin glue for persistent pneumothorax in an extremely low birth weight infant. Indian Pediatr 43(7):646
Bhatia J, Mathew OP (1985) Resolution of pneumothorax in neonates. Crit Care Med 13(5):417–419
Fréchette J-P, Martineau I, Gagnon G (2005) Platelet-rich plasmas: growth factor content and roles in wound healing. J Dent Res 84(5):434–439
Masuki H, Okudera T, Watanebe T, Suzuki M, Nishiyama K, Okudera H et al (2016) Growth factor and pro-inflammatory cytokine contents in platelet-rich plasma (PRP), plasma rich in growth factors (PRGF), advanced platelet-rich fibrin (A-PRF), and concentrated growth factors (CGF). Int J Implant Dent 2:1–6
Keshvari Shirvan M, Hamidi Alamdari D, Ghoreifi A (2014) A novel method for iatrogenic vesicovaginal fistula treatment: autologous platelet rich plasma injection and platelet rich fibrin glue interposition. Int J Pediatr 2(2.3):29
Alamdari DH, Motie MR, Kamalahmadi N, Aliakbarian M (2019) Autologous platelet-rich plasma and fibrin glue decrease pain following excision and primary closure of pilonidal sinus. Adv Skin Wound Care 32(5):234–237
Acknowledgements
None declared
Funding
None.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
This study was approved by the ethic committee of the Mashhad University of Medical Sciences (Ethical code: 981289, January 2, 2017). Informed consent was obtained from parents.
Human rights
The study was approved by the ethic committee of the Mashhad University of Medical Sciences (Ethical code: 981289, January 2, 2017).
Informed consent
Informed consent was obtained from parents.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Supplementary file1 (MP4 991 KB)
Supplementary file2 (MP4 2196 KB)
Supplementary file3 (MP4 2039 KB)
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Maleki, M.H., Tashnizi, M.A., Shahri, H.M.M. et al. Persistent pneumothorax treatment following congenital cardiac surgery by platelet–fibrin glue. Updates Surg 76, 647–652 (2024). https://doi.org/10.1007/s13304-023-01728-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13304-023-01728-9